A Phase II Study of Abraxane Combined With Gemcitabine in the Patients With Metastatic Breast Cancer
Phase of Trial: Phase II
Latest Information Update: 07 Jun 2016
At a glance
- Drugs Gemcitabine (Primary) ; Paclitaxel (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 07 Jun 2016 Results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology
- 08 Sep 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Dec 2013 Planned number of patients changed from 47 to 84 as reported by ClinicalTrials.gov.